After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Cross-sectional studies and Mendelian randomization show that insulin resistance and chronic inflammation mediate the ...

While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Residency program directors offer advice to medical residents, emphasizing that it’s okay to be unsure, explore different ...

Researchers conducted a prospective, longitudinal cohort study involving individuals with current or former habit, who had ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

The possession, sale, and production of psilocybin for recreational use are illegal in Canada. Why then, do brick-and-mortar ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

The first prospective study to look at this problem since investigators identified an issue earlier confirmed that clinicians ...

I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.

Early introduction of atorvastatin in patients with hypertension demonstrates sustained cardiovascular benefits, a 20-year ...

Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...